- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT04942392
Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic
Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic: A Feasibility Study
Dance as a treatment to support physical, cognitive and emotional functioning, has gained increased acceptance as a healthcare intervention for people with Parkinson's Disease (PD). The impact of the COVID-19 pandemic has been far reaching with devastating effects for at-risk populations. To find alternative and safe treatment delivery options during the pandemic has been of outmost importance.
This mixed-methods, feasibility study on digital for people with Parkinson's Disease aimed to investigate: (1) the feasibility and safety of a digital home-based dance intervention for people with PD; (2) change in self-reported quality of life, cognitive complaints, psychological health and fatigue; and (3) the experience of digital dance for people with PD.
Twenty-three participants partook in 10 weekly digital dance classes at home via zoom. Feasibility outcomes measures were administered at post-test. Pre-post changes in self-reported quality of life, cognitive complaints, psychological health and fatigue were measured, as well as the experience of digital dance via focus groups.
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
-
Stockholm, Szwecja
- Balettakademien
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
- Dziecko
- Dorosły
- Starszy dorosły
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Self-reported diagnosis of Parkinson's Disease
- Participant in Dance for PD at Balettakademien, Stockholm, Sweden
Exclusion Criteria:
- None
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie podtrzymujące
- Przydział: Nie dotyczy
- Model interwencyjny: Zadanie dla jednej grupy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: digital dance for PD
|
The digital dance class was held via Zoom.
The class was scheduled once a week for 60 min and consisted of 10 sessions.
A professional, certified Dance for PD and experienced dance instructor was teaching the dance class.
The dance classes followed the Dance for PD protocol yet was adjusted to fit the digital zoom format.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Feasibility outcome measures
Ramy czasowe: Assessed at post-test
|
The following feasibility outcome measures were assessed: (a) Technical and safety issues, (b) Compliance and motivation, (c) Self-assessed improvement in physical function, wellbeing and cognitive function and (d) The importance of dance as an artistic and creative activity. Each feasibility outcome measure was assessed via a 5-point Likert scale ranging from (1=very unsatisfactory, 5=very satisfactory), (1=not motivated, 5=very motivated), (1=noticeable worsening, 5=noticeable improvement) or (1=not meaningful, 5=very meaningful). Furthermore, each feasibility outcome measure had an open-ended question connected to it in order to capture any details related that feasibility domain. Two open-ended questions regarding positive and negative aspects of digital dancing were also included. For each feasibility outcome measure, a criterion of success was developed in order to judge the the success rate of these feasibility outcome measures. |
Assessed at post-test
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Depression and anxiety
Ramy czasowe: 12 weeks (pretest - posttest)
|
Severity of depression and anxiety symptoms measured by Hospital Anxiety Depression scale Anxiety score: 0-21 higher score indicate more anxiety Depression score: 0-21 higher score indicate more depression
|
12 weeks (pretest - posttest)
|
Quality of life (QoL) Summary index
Ramy czasowe: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39), Summary index: 0-100 higher scores indicate more problems. Furthermore, scores on the following subscales were assessed:
|
12 weeks (pretest - posttest)
|
Quality of life (QoL) - Bodily discomfort
Ramy czasowe: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale: Bodily discomfort score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) Communication
Ramy czasowe: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale: Communication score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) Cognition
Ramy czasowe: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale:Cognition score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) Social support
Ramy czasowe: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale: Social support score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) Stigma
Ramy czasowe: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale: Stigma score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) Emotional well being
Ramy czasowe: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale: Emotional well being score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) Activity of Daily Living
Ramy czasowe: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale: Activity of Daily Living score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Quality of life (QoL) - Mobility
Ramy czasowe: 12 weeks (pretest - posttest)
|
Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39). Subscale Mobility score: 0-100 higher scores indicate more problems |
12 weeks (pretest - posttest)
|
Fatigue
Ramy czasowe: 12 weeks (pretest - posttest)
|
Fatigue measured by Checklist Individual Strength Questionnaire (CIS).
Total score: 20-140
|
12 weeks (pretest - posttest)
|
Subjective cognitive complaints
Ramy czasowe: 12 weeks (pretest - posttest)
|
Improvement on subjective memory complaints measured by Prospective Retrospective Memory Questionnaire (PRMQ).
Total score: 16-80 higher scores indicate more cognitive complaints prospective score: 0-100 higher scores indicate more cognitive complaints retrospective score: 0-100 higher scores indicate more cognitive complaints short term score: 0-100 higher scores indicate more cognitive complaints long term score: 0-100 higher scores indicate more cognitive complaints self cued score: 0-100 higher scores indicate more cognitive complaints environmentally cued: 0-100 higher scores indicate more cognitive complaints
|
12 weeks (pretest - posttest)
|
Mental fatigue
Ramy czasowe: 12 weeks (pretest - posttest)
|
Two questions from the Mental Fatigue Scale were used to measure mental fatigue (item 3) and recovery (item 4).
Answers were given on a 7-point Likert scale.
|
12 weeks (pretest - posttest)
|
Experience and meaning of digital dance for people with PD
Ramy czasowe: Assessed at post-test
|
Two focus group interviews were conducted to examine the broader experience of digital dance for people with PD.
|
Assessed at post-test
|
Inne miary wyników
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Age
Ramy czasowe: Assessed at pre-test
|
Demographic characteristic: age at baseline
|
Assessed at pre-test
|
Sex
Ramy czasowe: Assessed at pre-test
|
Demographic characteristic: sex
|
Assessed at pre-test
|
Educational level
Ramy czasowe: Assessed at pre-test
|
Demographic characteristic: educational level
|
Assessed at pre-test
|
Previous experience of dance for Parkinson's Disease
Ramy czasowe: Assessed at pre-test
|
Demographic characteristic: previous experience of dance for PD
|
Assessed at pre-test
|
Self-evaluated health
Ramy czasowe: Assessed a pre-test
|
Demographic characteristic: self-evaluated health
|
Assessed a pre-test
|
Disease duration
Ramy czasowe: Assessed at pre-test
|
Demographic characteristic: self-reported year of PD diagnosis
|
Assessed at pre-test
|
Current participation in physical exercise
Ramy czasowe: Assessed at pre-test
|
Demographic characteristic: current participation in physical exercise
|
Assessed at pre-test
|
Współpracownicy i badacze
Sponsor
Współpracownicy
Śledczy
- Główny śledczy: Anna S Neely, prof, Umea University
Publikacje i pomocne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
- Choroby mózgu
- Choroby ośrodkowego układu nerwowego
- Choroby Układu Nerwowego
- Zakażenia koronawirusem
- Zakażenia Coronaviridae
- Infekcje Nidovirales
- Zakażenia wirusem RNA
- Choroby wirusowe
- Infekcje
- Infekcje dróg oddechowych
- Choroby Układu Oddechowego
- Zapalenie płuc, wirusowe
- Zapalenie płuc
- Choroby płuc
- Zaburzenia Parkinsona
- Choroby jąder podstawy
- Zaburzenia ruchowe
- Synukleinopatie
- Choroby neurodegeneracyjne
- COVID-19
- Choroba Parkinsona
Inne numery identyfikacyjne badania
- 136/2019
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Choroba Parkinsona
-
Bambino Gesù Hospital and Research InstituteZakończonyCiężka otyłość dziecięca (BMI > 97° szt. -według wykresów BMI Centers for Disease Control and Prevention-) | Zmienione testy czynnościowe wątroby | Nietolerancja glikemicznaWłochy
-
Spero TherapeuticsZakończonyKompleks Mycobacterium Avium | Niegruźlicze Mycobacterium Pulmonary DiseaseStany Zjednoczone
-
Janssen Pharmaceutical K.K.RekrutacyjnyOporna na leczenie Mycobacterium Avium Complex-lung Disease (MAC-LD)Tajwan, Republika Korei, Japonia
-
Adelphi Values LLCBlueprint Medicines CorporationZakończonyBiałaczka z komórek tucznych (MCL) | Agresywna mastocytoza układowa (ASM) | SM w Assoc Clonal Hema Lineage Non-mast Cell Lineage Disease (SM-AHNMD) | Tląca się mastocytoza układowa (SSM) | Indolentna układowa mastocytoza (ISM) Podgrupa ISM w pełni zatrudnionaStany Zjednoczone